Contineum Therapeutics
CTNM
#8263
Rank
$0.33 B
Marketcap
$8.90
Share price
-33.43%
Change (1 day)
-25.37%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Contineum Therapeutics CIK: 0001855175

Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2026 Q2

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2026 Q1

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2025 Q3

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2025 Q2

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2025 Q1

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2024 Q3

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2024 Q2

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Contineum Therapeutics 10-Q Quarterly Report FY2024 Q1

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)